June is National Cancer Survivor’s Month
According to the National Cancer Institute, an individual is considered a cancer survivor from the time of diagnosis through the balance of his or her life. In addition, because a cancer diagnosis also affects family members, friends, and caregivers, they too are considered cancer survivors.
A goal of the 2015-2020 NH Comprehensive Cancer Plan is to optimize quality of life for those affected by cancer. As the number of cancer survivors continues to increase, more services will be needed to treat the physical, psychological, social, spiritual, and financial issues faced by cancer survivors. Of the nearly 14.5 million estimated cancer survivors in the U.S as of January 2014, NH accounts for over 77,000. Although it is great news that there are increasing numbers of survivors, we are challenged to meet their needs and improve their quality of life. NH CCC’s Quality of Life Task Force recently developed an informational card for people who experience pain as result of their cancer or cancer treatment, that suggests options to consider to prevent and manage their pain including many non-pharmaceutical approaches.
The New Hampshire Comprehensive Cancer Collaboration (NH CCC) works in collaboration with its partners to stay up-to-date with the innovative approaches to address survivorship issues. In an effort to increase public awareness about cancer survival and decrease the incidence of this disease, NH CCC joins national and statewide organizations to promote National Cancer Survivors Month.
Together – Eliminating Cancer.
Featured Partner: Donna Dubuc
Donna Dubuc, MBA, CCPH, board member for NH Comprehensive Cancer Collaboration (NH CCC) has more than 25 years’ experience in health communications overseeing marketing, media relations, and public relations. She has a specialized interest in public health messaging to reduce at-risk behavior and increase awareness of public health threats like cancer.
Donna has supported communications for community hospital cancer programs in Claremont, Keene and Manchester. She also spent a number of years as Director of Communications at Dartmouth-Hitchcock Norris Cotton Cancer Center in Lebanon. Currently she is a member of the marketing team at Foundation Medicine, a Cambridge, Massachusetts molecular information company that analyzes cancer-related genes to improve cancer care through precision oncology.
“I think the rapidly expanding knowledge surrounding the molecular underpinnings of cancer will change the way cancer is diagnosed, categorized and treated,” said Dubuc. “I am pleased to bring a connection to genomic medicine to my work with the Collaboration.”
As a member of the NH CCC’s Communications Committee for three years before being appointed to the Board of Directors, Donna provided ongoing input and support on a range of issues and projects to reduce the state’s cancer burden. She was part of the initial team that launched NH CCC’s emerging issue briefs, overseeing the production of the briefs for more than one year.
Follow us on Facebook
News and Events
Changes For Colon Cancer Screening: 5 Things To Know Now, NHPR, 6/24/16
Doctors, patients urge legislation to improve hospice, palliative care, Modern Healthcare, 6/23/16
Cause Celeb: Rory Feek brings Capitol Hill audience to tears, Washington Post, 6/23/16
Task Force Meets on Seacoast Cancer Cluster, NHPR, 6/22/16
Lowell healthboard bans tobacco sales to those under 21, Lowell Sun, 6/15/16
Enhanced Risk-Based Lung Cancer Screening May Prevent More Deaths than Current Approaches, National Cancer Institute, 6/2/16
Nonprofit supports skin cancer prevention; Grassroots organization provides sunscreen dispensers, Dermatology Times, 6/3/16
Help accelerate end of breast cancer, Fosters.com, 5/26/16
Do Doctors Really Die Differently Than the Rest of Us?, Pacific Standard, 5/23/16
Kicking the Habit: Adult Smoking Rate in US is Falling Fast, Associated Press, 5/24/16
Patients, doctors engage in end-of-life talks; As of Jan. 1, Medicare paying for conversations, Seacoast Online, 5/24/16
EPA issues health advisory for long-term PFOA exposure, Union Leader, 5/19/16
FDA Approves Roche Immunotherapy for Bladder Cancer, Wall Street Journal, 5/18/16